SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?
7 references·0 citing·19 second hop
Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts? (2018)Was the Myriad decision a 'surgical strik…After Myriad, what makes a gene patent claim 'markedly different' from nature? (2017)After Myriad, what makes a ge…The changing life science patent landscape (2016)The changing life science pat…Myriad's impact on gene patents (2016)Myriad's impact on gene paten…The History of Patenting Genetic Material (2015)The History of Patenting Gene…遺伝子特許に関する米国連邦最高裁判決の意義[Ass'n for Molecular Pathology (AMP) v. Myriad Genetics, Inc., 133 S. Ct. 2107, 186 L. Ed. 2d 124 (2013)] (2013)遺伝子特許に関する米国連邦最高裁判決の意義[Ass'n f…Moving Beyond “Isolated” Gene Patents (2013)Moving Beyond “Isolated” Gene…AMP v. Myriad : A Surgical Strike on Blockbuster Business Models (2013)AMP v. Myriad : A Surgical St…DNA patents and diagnostics: not a pretty picture (2010)Myriad Genetics: In the eye of the policy storm (2010)Not quite a myriad of gene patents (2013)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh–Dole act of 1980 (2001)The Immortal Life of Henrietta Lacks (2011)Models of Technology Transfer for Genome-Editing Technologies (2020)Collective intellectual property of Indigenous peoples and local communities: Exploring power asymmetries in the rooibos geographical indication and industry-wide benefit-sharing agreement (2023)Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options (2009)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Determinants of Market Exclusivity for Prescription Drugs in the United States (2017)Markets for Technology (2001)Patents in Genomics and Human Genetics (2010)Markets for Technology (2013)International Divergence in Gene Patenting (2019)European patent protection for medical uses of known products and drug repurposing (2022)Patent landscaping for life sciences innovation: toward consistent and transparent practices (2013)Continental drift? Do European clinical genetic testing laboratories have a patent problem? (2019)Intellectual property rights derived from academic research and their role in the modern bioeconomy—A guide for scientists (2017)
this work references cited by second hop

References

  • 2015The History of Patenting Genetic Material63 cited
  • 2013遺伝子特許に関する米国連邦最高裁判決の意義[Ass'n for Molecular Pathology (AMP) v. Myriad Genetics, Inc., 133 S. Ct. 2107, 186 L. Ed. 2d 124 (2013)]35 cited
  • 2017After Myriad, what makes a gene patent claim 'markedly different' from nature?21 cited
  • 2016Myriad's impact on gene patents19 cited
  • 2013Moving Beyond “Isolated” Gene Patents16 cited
  • 2016The changing life science patent landscape11 cited
  • 2013AMP v. Myriad : A Surgical Strike on Blockbuster Business Models11 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work